1. Home
  2. FLOC vs CNTA Comparison

FLOC vs CNTA Comparison

Compare FLOC & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLOC
  • CNTA
  • Stock Information
  • Founded
  • FLOC 1996
  • CNTA 2020
  • Country
  • FLOC United States
  • CNTA United Kingdom
  • Employees
  • FLOC N/A
  • CNTA N/A
  • Industry
  • FLOC Metal Fabrications
  • CNTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • FLOC Industrials
  • CNTA Health Care
  • Exchange
  • FLOC Nasdaq
  • CNTA Nasdaq
  • Market Cap
  • FLOC 1.9B
  • CNTA 1.6B
  • IPO Year
  • FLOC 2025
  • CNTA 2021
  • Fundamental
  • Price
  • FLOC $17.18
  • CNTA $13.51
  • Analyst Decision
  • FLOC Strong Buy
  • CNTA Strong Buy
  • Analyst Count
  • FLOC 5
  • CNTA 11
  • Target Price
  • FLOC $33.40
  • CNTA $27.00
  • AVG Volume (30 Days)
  • FLOC 440.1K
  • CNTA 730.3K
  • Earning Date
  • FLOC 05-13-2025
  • CNTA 05-14-2025
  • Dividend Yield
  • FLOC 0.46%
  • CNTA N/A
  • EPS Growth
  • FLOC N/A
  • CNTA N/A
  • EPS
  • FLOC 2.69
  • CNTA N/A
  • Revenue
  • FLOC $660,916,000.00
  • CNTA $15,000,000.00
  • Revenue This Year
  • FLOC $54.81
  • CNTA N/A
  • Revenue Next Year
  • FLOC $12.05
  • CNTA N/A
  • P/E Ratio
  • FLOC $6.39
  • CNTA N/A
  • Revenue Growth
  • FLOC 156.58
  • CNTA 118.88
  • 52 Week Low
  • FLOC $16.63
  • CNTA $7.90
  • 52 Week High
  • FLOC $30.50
  • CNTA $19.09
  • Technical
  • Relative Strength Index (RSI)
  • FLOC N/A
  • CNTA 56.37
  • Support Level
  • FLOC N/A
  • CNTA $12.11
  • Resistance Level
  • FLOC N/A
  • CNTA $13.23
  • Average True Range (ATR)
  • FLOC 0.00
  • CNTA 0.73
  • MACD
  • FLOC 0.00
  • CNTA 0.12
  • Stochastic Oscillator
  • FLOC 0.00
  • CNTA 98.13

About FLOC Flowco Holdings Inc. Class A Common Stock

Flowco Holdings Inc is a provider of production optimization, artificial lift and methane abatement solutions for the oil and natural gas industry. Its technologies include high pressure gas lift (HPGL), conventional gas lift, plunger lift and vapor recovery unit (VRU) solutions. The company operates in two reportable segments: Production Solutions which include rental services and Natural Gas Technologies which include service gas compression parts and equipment sales. Production Solutions: relates to rentals, sales and services related to high pressure gas lift, conventional gas lift and plunger lift; including other digital solutions and methane abatement technologies, and has maximum revenue.

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

Share on Social Networks: